Form 4: Kewaunee Scientific Corp Executive Equity Transactions

Mandar Ranade, SVP of IT & Engineering at Kewaunee Scientific Corp, reported equity transactions on June 30, 2026, involving restricted stock units and common stock.

Summary

• Mandar Ranade, SVP of IT & Engineering at Kewaunee Scientific Corp, engaged in several equity transactions on June 30, 2026.
• These transactions included the settlement of performance-based and service-based restricted stock units (RSUs).
• Performance-based RSUs vested at 150% of target, resulting in the settlement of 3,627 RSUs.
• The settlement involved the issuance of 3,641 shares and a cash payment in lieu of 1,800 shares.
• Additionally, 518 service-based RSUs vested, leading to the receipt of shares.
• In total, 4,159 shares were received from the settlement of RSUs.
• The reporting person also disposed of 1,800 shares at $36.25 and 1,877 shares at $36.25.
• Following these transactions, the reporting person beneficially owns 19,892 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting on routine executive equity transactions and vesting events, with no significant positive or negative financial news.

Positives

• Performance-based RSUs vested at 150% of target, indicating strong performance against goals.
• The settlement of RSUs resulted in the acquisition of 4,159 shares by the reporting person.
• The reporting person continues to hold a significant number of shares (19,892) after the reported transactions.

Negatives

• The reporting person disposed of 3,677 shares of common stock in two separate transactions.
• A portion of the RSU settlement was received in cash, not shares, for 1,800 RSUs.

Future Outlook

The filing details past transactions and current beneficial ownership, and does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider equity transactions, providing transparency into executive compensation and potential stock sales. The performance-based vesting at 150% of target suggests Kewaunee Scientific Corp may have met or exceeded certain performance benchmarks during the relevant period.

Stakeholder Impact

• Shareholders: The transactions provide insight into executive compensation and potential stock sales, which can influence market perception.
• Employees: The vesting of RSUs reflects performance achievements and compensation for key personnel.
• Management: The filing details the compensation structure and equity holdings of a senior executive.

Key Dates

Keywords

Kewaunee Scientific Corp, Form 4, SEC Filing, Equity Transaction, Restricted Stock Units, RSU Settlement, Beneficial Ownership, Insider Trading, Stock Vesting, Executive Compensation